Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Shelan, Mohamed; Mercier, Carole; Achard, Vérane; Thon, Kristian; Stellamans, Karin; Moon, Daniel; Conde-Moreno, Antonio; Papachristofilou, Alexandros; Scorsetti, Marta; Gückenberger, Matthias; Ameye, Filip; Zapatero, Almudena; ... (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European urology focus, 7(2), pp. 241-244. Elsevier 10.1016/j.euf.2020.12.010
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S2405456920303126-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (808kB) |
Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Shelan, Mohamed |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2405-4569 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Beatrice Scheidegger |
Date Deposited: |
04 Feb 2021 15:06 |
Last Modified: |
05 Dec 2022 15:45 |
Publisher DOI: |
10.1016/j.euf.2020.12.010 |
PubMed ID: |
33386290 |
BORIS DOI: |
10.48350/151170 |
URI: |
https://boris.unibe.ch/id/eprint/151170 |
Actions (login required)
 |
Edit item |